Stem Cell Transplant Clinical Trial
Official title:
Comparison of Outcome of Mesenchymal Stem Cells And Skin Graft With Skin Graft In Management of Traumatic Heel Pad Injuries of Children
Trauma is the leading cause of soft tissue loss of the heel. Children constitute the largest group of victims of such injuries. Spoke wheel injury, road traffic accident are common mode in the children. Oestern and Tscherne have classified soft tissue injuries into four grades from 0-4. The treatment of Grade 0 and 1 injuries is typical cleansing and application of a moist wound healing dressing. But further grades need surgical management with debridement and reconstruction. Grade III and IV can be reconstructed by using graft, flaps or various other techniques. . Skin grafting offers poor functional and cosmetic results, although it is commonly performed with good take rates. mesenchymal stem cells will be isolated from umbilical cord with informed consent from the mothers. This study will open a new avenue for the treatment of heel pad injury. . Since the use of stem cell (especially in Pakistan) is completely a new technique in the management of heel pad injury, it will provide insight for better management by accelerating the wound healing process.
Trauma is the leading cause of soft tissue loss of the heel. Children constitute the largest
group of victims of such injuries. Spoke wheel injury, road traffic accident are common mode
in the children. These injuries can range from simple minor abrasions, lacerations to
crushing of heel. Injury to heel pad and flap has serious impact in day to day life, causing
disability because it is the major weight bearing area and inherently lacks adequate soft
tissue.
Management of injury of heel pad in children depends on severity and extent of soft tissue
injury. Oestern and Tscherne have classified soft tissue injuries into four grades from 0-4.
The treatment of Grade 0 and 1 injuries is typical cleansing and application of a moist wound
healing dressing. But further grades need surgical management with debridement and
reconstruction.
Grade III and IV can be reconstructed by using graft, flaps or various other techniques.
Simple skin graft, lateral rotational skin flap, local muscle flaps, ingenious
fasciocutaneous island flaps, cross-leg or cross foot flap, free tissue transfer and staged
or distant jumped flaps are historically included in reconstructive ladder in repairing these
soft tissue injuries. Generally, free flap reconstruction is the ultimate step of degloving
wound coverage. Despite availability of various reconstructive techniques, covering of soft
tissue loss of heel in traumatic events, remains a difficult and demanding procedure,
especially when it is associated with fractures and complex wounds. Skin grafting offers poor
functional and cosmetic results, although it is commonly performed with good take rates.
Stem cells are potential alternative to promote cutaneous wound healing because of its unique
features like self-renewal and differentiation capacity. Mesenchymal stem cells are type of
adult stem cells that reside in various tissues of the body. Besides, these cells are
preferred for cell based therapies because they have immunomodulatory properties. These cells
can be isolated from bone marrow, adipose tissue and human umbilical cord blood and tissue.
Recently,umbilical cord derived mesenchymal stem cells have shown a tremendous potential for
use in tissue engineering and regenerative medicine. Previous studies indicate that these
mesenchymal stem cells can accelerate wound healing by enhanced proliferation and migration
of human fibroblast, enhancing secretion of elastin, synthesizing collagen, angiogenesis and
further maturing blood vessels present in wound site. Stem cell-based therapies will
definitely be the major part of clinical medicine in next decade.
In the current study, mesenchymal stem cells will be isolated from umbilical cord with
informed consent from the mothers. This study will open a new avenue for the treatment of
heel pad injury. Considering the role of stem cells in wound healing, study has been designed
to accelerate the wound healing process in children with heel pad injury. Since the use of
stem cell (especially in Pakistan) is completely a new technique in the management of heel
pad injury, it will provide insight for better management by accelerating the wound healing
process, reducing the hospital stay and cost of treatment. Rationale of our study aims to
compare outcome of heel pad injury managed with skin graft with infiltration of mesenchymal
stem cell Versus management with skin graft only.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03641378 -
Inpatient Palliative Care for Patients Undergoing Hematopoietic Stem Cell Transplantation
|
N/A | |
Recruiting |
NCT06155188 -
Post-transplant PT/FLU+CY Promotes Unrelated Cord Blood Engraftment in Haplo-cord Setting in Childhood Leukemia
|
N/A | |
Recruiting |
NCT03562065 -
Treatment of Refractory Systemic Lupus Erythematosus by Allogeneic Mesenchymal Stem Cells Derived From the Umbilical Cord
|
Phase 1/Phase 2 | |
Completed |
NCT01468935 -
Bone Marrow Cell Engraftment of the Uterus and Genetic Studies of Reproductive Functioning
|
||
Active, not recruiting |
NCT03938324 -
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions
|
N/A | |
Not yet recruiting |
NCT03259217 -
Clinical Application of Mesenchymal Stem Cells Seeded in Chitosan Scaffold for Diabetic Foot Ulcers
|
Phase 1 | |
Recruiting |
NCT01189786 -
Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection
|
N/A | |
Recruiting |
NCT04610359 -
Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis
|
Phase 1 | |
Completed |
NCT05712148 -
Spheroidal Mesenchymal Stem Cells in Retinitis Pigmentosa
|
Phase 1/Phase 2 | |
Recruiting |
NCT05515497 -
BMT4me: Post-HSCT Medication Adherence mHealth App
|
N/A | |
Completed |
NCT01984671 -
Mobile Pain Coping Skills Training for Stem Cell Transplant Patients
|
N/A | |
Not yet recruiting |
NCT06075927 -
Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT
|
Phase 1/Phase 2 | |
Completed |
NCT03440775 -
Digital Stories and Psychosocial Wellbeing in Stem Cell Transplant Patients
|
N/A | |
Recruiting |
NCT02652052 -
Hematopoietic Stem Cell Transplant Survivors Study
|
N/A | |
Not yet recruiting |
NCT04922970 -
Strength Training as Prevention and Treatment of Late Effects in Long-term Survivors of Pediatric HSCT.
|
N/A | |
Completed |
NCT01092195 -
Gardasil Vaccination in Post Stem Cell Transplant Patients
|
Phase 1 | |
Completed |
NCT04041219 -
Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients
|
Phase 4 | |
Completed |
NCT00656058 -
Montelukast to Treat Bronchiolitis Obliterans
|
Phase 2 | |
Recruiting |
NCT04375579 -
Assessment of Elderly Undergoing Allogeneic Hematopoietic Stem Cell Transplantation
|
||
Completed |
NCT03859765 -
In Person and mHealth Coping Skills Training for Symptom Management and Steps in Stem Cell Transplant Patients
|
N/A |